- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
I am a Consultant Gastroenterologist at the Royal Free Hospital and Department Chair of Gastroenterology for Cleveland Clinic London
I undertook my initial medical studies at Cambridge University, later qualifying with distinction from the University of London. Between 2001 and 2005 I undertook my initial research period at St Mark's Hospital, concentrating on both basic and clinical science, leading to the award of a PhD in 2006 from Imperial College London.
My clinical practice encompasses all aspects of gastroenterology with specific interests in endoscopy, inflammatory bowel disease, functional gut disorders including IBS
I was Senior Secretary of the British Society of Gastroenterology 2009-2013 and am currently Chair of the Education Committee for United European Gastroenterology. I am Past President of the Gastroenterology and Hepatology Section of the Royal Society of Medicine
My main academic focus is in Inflammatory Bowel Disease and I am Associate Professor of Medicine at the Cleveland Clinic
Areas of interest
Functional bowel disorders; Dyspepsia (indigestion); Bowel disease including inflammatory (IBD); Endoscopic procedures; Nutrition; Obesity
Current NHS consultant posts held
Royal Free Hospital
Inflammatory Bowel Disease
I like to keep fit and have partaken in several Ironman triathlons, marathons and SwimRun events. i am doing the London Marathon this year.
For my work to date I was awarded the Moti L. & Kamla Rustgi International Fellowship by the American Gastroenterological Association in 2005 and in 2007 was the Functional Brain-Gut Research Group Young Investigator of the Year.
Murray CDR et al. The Effect of Acute Physical and Psychological Stress on Gut Autonomic Innervation in Irritable Bowel Syndrome.
Murray CDR et al Ghrelin Enhances Gastric Emptying in Diabetic Gastroparesis. Gut 2005. Dec;54(12):1693-8
Hansi N ..Murray CD Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis. Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-214-21. Epub 2014 Nov 5
Malatinkova E..Murray C, Kinloch-de Loes S, Vandekerckhove L. Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs. Elife. 2015 Oct 6;4:e09115. doi: 10.7554/eLife.09115
Kennedy NA, Murray CD et al; UK Anti-TNF withdrawal study group., Lees CW. Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis. Aliment Pharmacol Ther. 2016 Apr;43(8):910-923.
Mowat C, Murray C TOPPIC Study Group. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial. Lancet Gastroenterol Hepatol. 2016 Dec;1(4):273-282. doi: 10.1016/S2468-1253(16)30078-4
Brooks AJ, Smith PJ, Cohen R, Collins P, Douds A, Forbes V, Gaya DR, Johnston BT, McKiernan PJ, Murray CD, Sebastian S, Smith M, Whitley L, Williams, L, Russell RK, McCartney SA, Lindsay JO. UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care. Gut. 2017 Jun;66(6):988-1000. doi: 10.1136/gutjnl-2016-313000. Epub 2017 Feb 21.PMID: 28228488
Walker GJ, Harrison JW, Heap GA IBD Pharmacogenetics Study Group. Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease. JAMA. 2019 Feb 26;321(8):773-785. doi: 10.1001/jama.2019.0709.
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Kennedy NA..Murray CD et al.Gut. 2020 Jun;69(6):984-990. doi: 10.1136/gutjnl-2020
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Kennedy NA.. Murray CD et al; Contributors to the CLARITY IBD study.Gut. 2021 May;70(5):865-875. doi: 10.1136/gutjnl-2021-324388. Epub 2021 Mar 22.
Reference number 4328153
Information for healthcare professionals (Bupa patients only, last 12 months)
Diagnostic oesophago-gastro-duodenoscopy (OGD) and immediate colonoscopy includes forceps biopsies, biopsy test and dye spray (as sole procedure) - (5-50)
Diagnostic colonoscopy, includes forceps biopsy of colon and ileum - (5-50)
Diagnostic oesophago-gastro-duodenoscopy (OGD) includes forceps biopsy, biopsy urease test and dye spray - (5-50)
Diagnostic flexible sigmoidoscopy (including forceps biopsy and proctoscopy) - (1-5)
Small bowel capsule endoscopy (including interpretation and evaluation) - (1-5)
- Show All (7 )...